Status:
TERMINATED
Study of the Proteome and Cytokines During Inflammatory Syndromes of Different Etiologies.
Lead Sponsor:
Centre Hospitalier Universitaire Dijon
Conditions:
Inflammatory Disease
Eligibility:
All Genders
18-90 years
Phase:
NA
Brief Summary
The hypotheses of our research are based on the fact that various pathological states, infection, cancer, inflammatory disease, can induce an inflammatory syndrome, through different pathways, even th...
Eligibility Criteria
Inclusion
- Patients presenting an inflammatory syndrome, defined by elevated C-reactive protein (CRP\>50mg/L), whose etiology is related to infection, cancer or an inflammatory disease.
- Patients not on treatment (corticoids, immunosuppressive drugs) during the 7 days preceding inclusion
- Age: 18-90 years
- Patients covered by the National Health Insurance Agency
- signed written informed consent form
Exclusion
- \- Any patient not meeting the inclusion criteria
- Pregnant patients
Key Trial Info
Start Date :
March 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2012
Estimated Enrollment :
97 Patients enrolled
Trial Details
Trial ID
NCT01903642
Start Date
March 1 2010
End Date
February 1 2012
Last Update
July 19 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de Dijon
Dijon, France, 21079